Literature DB >> 2514990

Low infusion rate digital subtraction angiography to predict regional perfusion in hepatic arterial chemotherapy.

J C Andrews1, D M Williams, B Shapiro, W D Ensminger.   

Abstract

Digital subtraction angiography (DSA) with a low injection rate of contrast (0.5 ml/sec) was studied as a means of predicting the regional perfusion of percutaneously placed catheters for hepatic arterial chemotherapy. In 64 hepatic artery catheter placements, conventional injection rate angiography (3-5 ml/sec) and low infusion rate DSA exams were compared to conventional radionuclide perfusion studies performed with Tc-99m-MAA. In 58 of 64 cases (90.6%) the conventional arteriogram correctly predicted the extent of hepatic perfusion, whereas in 63 of 64 cases (98%), the low flow DSA exam correctly predicted hepatic perfusion. The conventional arteriogram correctly predicted the extent of extrahepatic perfusion in 32 cases (50%), with a sensitivity of 100%, but a specificity of only 39.6%. The DSA exam was correct in defining the presence or absence of extrahepatic perfusion in 57 of 64 cases for a sensitivity of 82% and a specificity of 91%. Despite the quantitative difference between the low infusion rate DSA study and the chemotherapy infusion (10 ml/hr), it is a useful tool to assist in the correct positioning of temporary catheters for hepatic arterial chemotherapy.

Mesh:

Substances:

Year:  1989        PMID: 2514990     DOI: 10.1007/bf02575416

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  8 in total

1.  Mixing problems of low flow hepatic artery infusion. Improvement with small caliber double lumen balloon catheters.

Authors:  K H Barth; R J Lutz; P W Kremers; D L Miller
Journal:  Invest Radiol       Date:  1988-07       Impact factor: 6.016

2.  Hepatic arterial flow distribution with hepatic neoplasms: significance in infusion chemotherapy.

Authors:  C Charnsangavej; C H Carrasco; S Wallace; W Richli; T P Haynie
Journal:  Radiology       Date:  1987-10       Impact factor: 11.105

3.  Mixing studies during hepatic artery infusion in an in vitro model.

Authors:  R J Lutz; D L Miller
Journal:  Cancer       Date:  1988-09-15       Impact factor: 6.860

4.  Radionuclide angiography to predict patient response to hepatic artery chemotherapy.

Authors:  W D Kaplan; W D Ensminger; S E Come; E H Smith; C J D'Orsi; D C Levin; R W Takvorian; G D Steele
Journal:  Cancer Treat Rep       Date:  1980

5.  Hepatic arterial perfusion scintigraphy with Tc-99m-MAA. Use of a totally implanted drug delivery system.

Authors:  H A Ziessman; J H Thrall; P J Yang; S C Walker; E A Cozzi; J E Niederhuber; J W Gyves; W D Ensminger; M C Tuscan
Journal:  Radiology       Date:  1984-07       Impact factor: 11.105

6.  Changes of arterial blood flow patterns during infusion chemotherapy, as monitored by intra-arterially injected technetium 99m macroaggregated albumin.

Authors:  A G Bledin; E E Kim; V P Chuang; S Wallace; T P Haynie
Journal:  Br J Radiol       Date:  1984-03       Impact factor: 3.039

7.  Predicting tumor response in patients with colorectal hepatic metastases.

Authors:  J M Daly; J Butler; N Kemeny; S D Yeh; J A Ridge; J Botet; J R Bading; J J DeCosse; R S Benua
Journal:  Ann Surg       Date:  1985-09       Impact factor: 12.969

8.  99mTc-labeled macroaggregated albumin in intrahepatic arterial chemotherapy.

Authors:  A G Bledin; H M Kantarjian; E E Kim; S Wallace; V P Chuang; Y Z Patt; T P Haynie
Journal:  AJR Am J Roentgenol       Date:  1982-10       Impact factor: 3.959

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.